| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.06M | 968.88K | 460.40K | 365.72K | 760.88K | 898.07K |
| Gross Profit | 2.06M | 968.88K | 460.40K | 365.72K | 760.88K | 898.07K |
| EBITDA | -4.19M | -7.96M | -11.57M | -12.35M | -12.07M | -7.18M |
| Net Income | -4.48M | -6.76M | -8.88M | -12.65M | -10.72M | -6.22M |
Balance Sheet | ||||||
| Total Assets | 6.45M | 6.45M | 9.38M | 5.36M | 15.26M | 23.68M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 2.34M | 5.03M | 2.72M | 10.10M | 21.39M |
| Total Debt | 1.96M | 1.96M | 2.31M | 1.31M | 1.03M | 1.28M |
| Total Liabilities | 3.30M | 3.30M | 4.08M | 2.99M | 2.91M | 2.56M |
| Stockholders Equity | 3.15M | 3.15M | 5.31M | 2.38M | 12.36M | 21.11M |
Cash Flow | ||||||
| Free Cash Flow | -3.72M | -6.05M | -7.58M | -8.77M | -11.77M | -4.76M |
| Operating Cash Flow | -3.54M | -5.83M | -6.52M | -8.08M | -8.65M | -4.55M |
| Investing Cash Flow | -174.87K | -174.87K | -1.06M | -690.83K | -3.12M | -213.07K |
| Financing Cash Flow | 3.32M | 3.32M | 9.89M | 1.39M | 482.29K | 22.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
56 Neutral | AU$44.16M | ― | -49.72% | ― | ― | 10.78% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$129.65M | ― | -41.51% | ― | -40.74% | -21.21% | |
46 Neutral | AU$14.28M | ― | -143.71% | ― | 306.88% | ― | |
45 Neutral | AU$57.29M | -5.79 | -71.87% | ― | 7.65% | -19.13% | |
43 Neutral | AU$70.05M | ― | -138.54% | ― | ― | 16.61% | |
41 Neutral | AU$54.55M | ― | -159.86% | ― | 110.44% | 35.90% |
AnteoTech Ltd has announced a Notice of General Meeting concerning a potential spill meeting following its 2025 Annual General Meeting. This meeting, if necessary, is scheduled for November 26, 2025, in Brisbane. The announcement is significant as it could impact the company’s governance and strategic direction, potentially affecting stakeholders’ interests.
AnteoTech Ltd has announced the date for its Annual General Meeting, which is set to take place on November 26, 2025, in Brisbane. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and operational performance. The announcement outlines key dates for shareholders, including the deadline for director nominations and the availability of meeting details, underscoring the company’s commitment to transparent communication with its investors.
AnteoTech Ltd has entered into a Joint Development and Sales Agreement with Black Diamond Structures LLC to produce and commercialize an advanced battery product for the U.S. market. This collaboration combines AnteoTech’s Anteo X™ and BDS’s MOLECULAR REBAR® to improve the performance of high silicon lithium-ion batteries. The agreement aims to leverage BDS’s customer network and production capabilities to accelerate AnteoTech’s entry into the U.S. market. The partnership is expected to deliver significant benefits to battery manufacturers by enhancing energy density, charge rates, and battery life while reducing costs.
AnteoTech Ltd announced the issuance of 22,138,295 fully paid ordinary shares to staff as part of its Equity Incentive Plan for FY2025 performance outcomes. This move, compliant with the Corporations Act, reflects the company’s commitment to rewarding its employees and potentially strengthens its market position by aligning staff interests with corporate growth. The issuance is expected to have implications for stakeholders by potentially enhancing employee motivation and retention, thereby supporting the company’s operational and strategic goals.
AnteoTech Ltd has announced the quotation of 22,138,295 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code ADO, effective from August 28, 2025. This move is part of a previously announced transaction, and it is expected to impact the company’s financial operations by potentially increasing liquidity and market visibility, which could influence investor interest and stakeholder engagement.
AnteoTech Ltd has released its Full Year Results and Business Update, accompanied by a presentation and a live webinar hosted by the CEO, Merrill Gray. The announcement highlights the company’s ongoing commitment to addressing the growing demand for advanced material solutions in the global battery market and life sciences sector. This update is significant for stakeholders as it underscores AnteoTech’s strategic focus on innovation and sustainability, potentially impacting its market positioning positively.
AnteoTech Ltd has released its 2024 Corporate Governance Statement and Appendix 4G, as per ASX listing rules. This announcement, authorized by the company’s board, underscores AnteoTech’s commitment to transparency and regulatory compliance, which could enhance its reputation and trust among stakeholders in the advanced materials and life sciences sectors.
AnteoTech Ltd has released its FY2025 Annual Report, detailing its financial results for the year ending June 30, 2025. The report, authorized by the company’s board, highlights the company’s ongoing commitment to providing advanced material solutions in the battery and life sciences markets. This announcement underscores AnteoTech’s strategic focus on innovation and sustainability, potentially strengthening its position in the global market and offering implications for stakeholders interested in high-performance, cost-effective materials.
AnteoTech Ltd announced the cessation of 3,750,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth prospects.
AnteoTech Ltd has announced a proposed issue of 22,150,000 ordinary fully paid securities, with an expected issue date of August 29, 2025. This move is part of a placement or other type of issue, as disclosed to the ASX. The announcement could potentially impact the company’s operations by increasing its capital base, which may enhance its market positioning and provide additional resources for strategic initiatives.
AnteoTech Ltd has appointed Ms. Merrill Gray as the new Managing Director and Chief Executive Officer, effective August 19, 2025. Ms. Gray, who has been serving as the Interim MD & CEO, brings extensive experience in science, engineering, and business leadership, with a strong track record in commercializing advanced technologies. Her appointment is expected to enhance the company’s strategic focus and drive growth in product sales and shareholder value. Additionally, AnteoTech has completed its annual staff performance review, resulting in the issuance of approximately 22,150,000 ordinary shares to employees under the Short-Term Incentive Program, aimed at preserving cash resources and incentivizing employees to create shareholder value.
AnteoTech Ltd has decided not to proceed with a A$1.4 million grant from the Queensland Government under the Queensland Critical Minerals and Battery Technology Fund, as it would require an additional A$2.2 million investment from the company. Instead, AnteoTech has established cost-effective alternatives for commercial cell design performance testing, allowing it to focus resources on commercializing its market-ready products. This decision is expected to save the company approximately A$2.2 million in net cash flow and does not affect its eligibility for a separate A$4 million grant from the Australian Renewables Energy Agency.
AnteoTech Ltd announced the release of its Annual Report for the financial year ending June 30, 2025, scheduled for August 28, 2025, accompanied by a Results & Operational Update Presentation. Interim CEO and Managing Director Merrill Gray will host an investor call on the same day to provide a business update. This announcement is significant for stakeholders as it offers insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
AnteoTech Ltd has entered into a commission agency agreement with Kangshin Industrial Co., Ltd., a South Korean distributor, to access the burgeoning South Korean battery market. This strategic move is expected to enhance AnteoTech’s market presence and accelerate its entry into one of Asia’s largest and most advanced battery markets, aligning with its global expansion strategy and potentially increasing sales volumes through established local networks and infrastructure.
AnteoTech Ltd has received a $2.59 million cash rebate from the Australian Tax Office as part of the 2025 Research & Development Tax Incentive. This rebate relates to the company’s eligible R&D activities in its Advanced Battery Technologies and Life Science business units during the 2025 financial year. The acceleration of the R&D incentive aligns with the company’s strategic review, potentially enhancing its operational capabilities and industry positioning.
AnteoTech Ltd announced the cessation of 635,937 securities, specifically options that expired on August 1, 2025, without being exercised or converted. This cessation marks a routine adjustment in the company’s issued capital, potentially impacting its financial structuring and stakeholder interests.
AnteoTech Ltd has reported significant progress in its operations for the quarter ending June 2025, highlighted by a new Joint Development Agreement with Black Diamond Structures to enhance its presence in the US battery market. The company has also achieved key technical milestones in its battery technologies and secured a substantial sales order from the Serum Institute of India for its life sciences division. Additionally, AnteoTech has undertaken a strategic review and organizational restructure to focus on commercializing market-ready products, resulting in cost savings and a sharpened focus on revenue generation. These developments position AnteoTech to capitalize on growth opportunities in high-performance battery materials and life sciences, supported by strategic partnerships and government backing.